What lower the development of nanodrug?

  • Chong Qiu State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences

Abstract

Only a few nanomedicines have entered clinical application after over a decade and billions of dollars of investments in nanoscience and nanotechnology around the world. So, what lower the development of nanodrug? Recently, at our recent Editorial and Editorial Advisory Board meeting, we asked ourselves to address these questions and accelerate the development of nano pharmaceuticals. We will work with leaders in the area of drug supply to share our experiences and compare efforts around the world.

References

Sönksen M, Kerl K, Bunzen H. Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors. Medicinal Research Reviews. 2021, 42(1): 374-398. doi: 10.1002/med.21844

Tawfik M, Chen F, Goldberg JL, et al. Nanomedicine and drug delivery to the retina: current status and implications for gene therapy. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2022, 395(12): 1477-1507. doi: 10.1007/s00210-022-02287-3

Sun Q, Zhou Z, Qiu N, et al. Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization. Advanced Materials. 2017, 29(14). doi: 10.1002/adma.201606628

Cheng Z, Li Y, Zhao D, et al. Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy. Frontiers in Bioengineering and Biotechnology. 2022, 10. doi: 10.3389/fbioe.2022.994655

Qiu C, Xia F, Zhang J, et al. Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery. Research. 2023, 6. doi: 10.34133/research.0148

Such GK, Yan Y, Johnston APR, et al. Interfacing Materials Science and Biology for Drug Carrier Design. Advanced Materials. 2015, 27(14): 2278-2297. doi: 10.1002/adma.201405084

Lönn P, Kacsinta AD, Cui XS, et al. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics. Scientific Reports. 2016, 6(1). doi: 10.1038/srep32301

Gilleron J, Querbes W, Zeigerer A, et al. Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape. Nature Biotechnology. 2013, 31(7): 638-646. doi: 10.1038/nbt.2612

Qiu C, Wu Y, Guo Q, et al. Preparation and application of calcium phosphate nanocarriers in drug delivery. Materials Today Bio. 2022, 17: 100501. doi: 10.1016/j.mtbio.2022.100501

Qiu C, Wu Y, Shi Q, et al. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy. International Journal of Biological Sciences. 2023, 19(3): 789-810. doi: 10.7150/ijbs.79328

Published
2024-01-08
How to Cite
Qiu, C. (2024). What lower the development of nanodrug?. Materials Technology Reports, 2(1), 460. https://doi.org/10.59400/mtr.v2i1.460
Section
Editorial